Federal Register / Vol. 74, No. 140 / Thursday, July 23, 2009 / Notices 36491 

ESTIMATED ANNUALIZED BURDEN TABLE

Forms Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Web-based Survey ........................... ECCS Coordinators .......................... 52 1 0.75 39 

Web-based Survey ........................... State Team Members ...................... 260 1 0.3 78 

Telephone Interview .......................... ECCS Coordinators .......................... 52 1 1.5 78 

Indicator Reporting System .............. ECCS Coordinators .......................... 52 1 1.5 78 

Total ........................................... 416 ........................ ........................ 273 

E-mail comments to 

paperwork@hrsa.gov or mail the HRSA 

Reports Clearance Officer, Room 10–33, 

Parklawn Building, 5600 Fishers Lane, 

Rockville, MD 20857. Written comments 

should be received within 60 days of 

this notice. 

Dated: July 16, 2009. 

Alexandra Huttinger, 

Director, Division of Policy Review and 

Coordination. 

[FR Doc. E9–17429 Filed 7–22–09; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration on Aging 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; SMP 

(Formerly Senior Medicare Patrol) 

Program Outcome Measurement 

AGENCY: Administration on Aging, HHS. 

ACTION: Notice. 

SUMMARY: The Administration on Aging 

(AoA) is announcing that the proposed 

collection of information listed below 

has been submitted to the Office of 

Management and Budget (OMB) for 

review and clearance under the 

Paperwork Reduction Act of 1995. 

DATES: Submit written comments on the 

collection of information by August 24, 

2009. 

ADDRESSES: Submit written comments 

on the collection of information by fax 

202.395.6974 to the OMB Desk Officer 

for AoA, Office of Information and 

Regulatory Affairs, OMB. 

FOR FURTHER INFORMATION CONTACT: 

Doris Summey, telephone (202) 357– 

3533; e-mail: 

doris.summey@aoa.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, AoA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Grantees are required by Congress to 

provide information for use in program 

monitoring and for Government 

Performance and Results Act (GPRA) 

purposes. This information collection 

reports the number of active volunteers, 

issues and inquiries received, other 

SMP program outreach activities, and 

the number of Medicare dollars 

recovered, among other SMP 

performance outcomes. This 

information is used as the primary 

method for monitoring the SMP 

Projects. 

AoA estimates the burden of this 

collection of information as follows: 

Respondents: 54 SMP grantees at 23 

hours per month (276 hours per year, 

per grantee). Total Estimated Burden 

Hours: 14,904 hours per year. 

Dated: July 17, 2009. 

Kathy Greenlee, 

Assistant Secretary for Aging. 

[FR Doc. E9–17528 Filed 7–22–09; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–09–08AA] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–5806. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Evaluation of health communication 

messages for Infertility Prevention 

Campaign—New—National Center for 

HIV/AIDS, Viral Hepatitis, Sexually 

Transmitted Diseases, and Tuberculosis 

Elimination Programs (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

The purpose of the proposed study is 

to develop, test, implement, and 

evaluate the effectiveness and 

satisfaction with Chlamydia health 

messages, products, and methods of 

dissemination. 

Chlamydia (CT) is among the leading 

causes of pelvic inflammatory disease 

(PID), which can lead to infertility, 

ectopic pregnancy, and chronic pelvic 

pain. Most cases of CT are 

asymptomatic so infected girls and 

women are unaware of their infections. 

CDC estimates that in 2006, young 

women aged 15 to 19 years had the 

highest CT rate (2,862 cases per 100,000 

females), followed by women aged 20 to 

24 (2,797 cases per 100,000 females). 

These rates are likely to be 

underestimates, because many infected 

persons do not seek medical care and 

testing. Data at CDC suggests that CT 

develops into PID in up to 40% of 

untreated women and that 12% of 

women are infertile after their first 

experience with PID. 

CDC plans to obtain public 

preferences that will guide the 

development of health communication 

messages/materials about CT with 

females in the following age groups: 15– 

17 years who attend school; 15–17 years 

who do not attend school: 18–25 years 

who are employed: And 18–25 years 

who attend school full-time. Focus 

groups will be conducted at local predetermined focus group facilities, and 

surveys will be conducted online and in 

malls. Women ages 18–25 years, both 

employed and working full-time, will be 

recruited by phone through professional 

recruitment vendors for focus groups; 

and in malls and on social networking 

sites for surveys. Girls ages 15–17 years, 

who do and do not attend school fulltime, will be recruited by phone through 

professional recruitment vendors for 

focus groups, after obtaining parental 

consent; and, in malls and through 


erowe on DSK5CLS3C1PROD with NOTICES
36492 Federal Register / Vol. 74, No. 140 / Thursday, July 23, 2009 / Notices 

social networking sites (without 

parental consent) for surveys. The 

Academy for Educational Development 

will be conducting the research. There 

is no cost to respondents other than 

their time. The total estimated annual 

burden hours are 481. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number 

of responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Parents of 15–17 yr old .................................. Focus Group Screener for Parents of Minors 54 1 5/60 

Females (15–17 yr old) ................................... Focus Group Screener for Minors ................. 54 1 5/60 

Female (18–25 yr old) .................................... Focus Group Screener for Adult Women ...... 126 1 5/60 

Female (15–25 yr old) .................................... Focus Group Moderator Guide (15–25) ........ 180 1 2 

Female (15–25 yr old) .................................... Mall Intercept Screener & Moderator Guide 

(15–25).

200 1 10/60 

Female (15–25 yr old) .................................... Online Screener and Survey (15–25) ............ 500 1 8/60 

Dated: July 16, 2009. 

Marilyn S. Radke, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E9–17525 Filed 7–22–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[ATSDR–253] 

Availability of Draft Toxicological 

Profile for Perfluoroalkyls 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of availability. 

SUMMARY: This notice announces the 

availability of the draft toxicological 

profile for perfluoroalkyls, prepared by 

ATSDR, for review and comment. 

DATES: In order to be considered, 

comments on this draft toxicological 

profile must be received on or before 

October 30, 2009. Comments received 

after the public comment period will be 

considered at the discretion of ATSDR 

on the basis of what is deemed to be in 

the best interest of the general public. 

ADDRESSES: Requests for a printed copy 

of the draft toxicological profile should 

be sent to the attention of Ms. Olga 

Dawkins, Division of Toxicology and 

Environmental Medicine, Agency for 

Toxic Substances and Disease Registry, 

Mailstop F–32, 1600 Clifton Road, NE., 

Atlanta, Georgia 30333. Electronic 

access to the document is also available 

at the ATSDR Web site: http:// 

www.atsdr.cdc.gov/toxpro2.html. 

Requests for printed copies of the 

draft toxicological profile must be in 

writing and must specifically identify 

the toxicological profile that you wish to 

receive. ATSDR reserves the right to 

provide free of charge only one copy of 

each profile requested. In case of 

extended distribution delays, requestors 

will be notified. 

Comments regarding the draft 

toxicological profile for perfluoroalkyls 

should be sent to the attention of Ms. 

Nickolette Roney, Division of 

Toxicology and Environmental 

Medicine, Agency for Toxic Substances 

and Disease Registry, Mailstop F–62, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333. Electronic comments may be 

sent to TPPublicComments@cdc.gov. All 

comments sent electronically should 

contain the docket control number 

ATSDR–253 in the subject line. 

Written comments and other data 

submitted in response to this notice and 

the draft toxicological profile should 

bear the docket control number ATSDR– 

253. Send one copy of all comments and 

three copies of all supporting 

documents to Ms. Roney at the above 

address by the end of the comment 

period. Because all public comments 

regarding ATSDR toxicological profiles 

are available for public inspection, no 

confidential information should be 

submitted in response to this notice. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Olga Dawkins, Division of Toxicology 

and Environmental Medicine, Agency 

for Toxic Substances and Disease 

Registry, Mailstop F–62, 1600 Clifton 

Road, NE., Atlanta, Georgia 30333; 

telephone number (800) 232–4636 or 

(770) 488–3315. 

SUPPLEMENTARY INFORMATION: This draft 

toxicological profile for perfluoroalkyls 

was prepared in accordance with 

guidelines developed by the Agency for 

Toxic Substances and Disease Registry 

and the Environmental Protection 

Agency (EPA) for the preparation of 

toxicological profiles. The original 

guidelines were published in the 

Federal Register on April 17, 1987. 

While perfluoroalkyls are not found on 

the ATSDR Priority List of Hazardous 

Substances, ATSDR has determined that 

a profile for these substances was 

necessary because data indicate that 

some perfluoroalkyls are found in the 

blood of the United States general 

population and in the environment. The 

agency also determined that it was 

important to characterize the current 

available information regarding the 

health effects from exposure to 

perfluoroalkyls in order to support and 

inform public health responses and 

activities by ATSDR and others. This 

profile will be revised and republished 

as necessary. 

Section 104(i)(3) of the 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act [42 U.S.C. 9604(i)(3)] outlines the 

content of the toxicological profiles. 

Each profile includes an examination, a 

summary, and an interpretation of 

available toxicological information and 

epidemiologic evaluations. This 

information and these data are to be 

used to identify the levels of significant 

human exposure to a substance and the 

associated health effects. The profiles 

must also include a determination of 

whether adequate information on the 

health effects of each substance is 

available or in the process of 

development. When adequate 

information is not available, ATSDR, in 

cooperation with the National 

Toxicology Program (NTP), will initiate 

a research program to determine these 

health effects. 

Although key studies for this 

substance were considered during the 

profile development process, this 

Federal Register notice solicits any 

additional studies, particularly 

unpublished data and ongoing studies, 

which will be evaluated for possible 

addition to the profile now or in the 

future. 


erowe on DSK5CLS3C1PROD with NOTICES